Stockholders' Deficiency

12 Months Ended

Dec. 31, 2011

Stockholders' Deficiency [Abstract]

Stockholders' Deficiency

7. Stockholders’ Deficiency

During 2011, the Company sold a total of 335,337 shares of its common stock to two non-affiliated individual investors for a total of $18,000 pursuant to a private placement. In November 2011, the Company entered into a Conversion Agreement with two individuals whereby unsecured loans in the aggregate principal amount of $6,500, including $1,500 representing a portion of an unsecured loan held by Herman M. Gerwitz, a Director, together with approximately $700 of accrued interest on one of the unsecured loans were converted into shares of restricted common stock of the Company at $0.045, the market price at the date of conversion. As a result, an aggregate of 159,088 shares of restricted common stock were issued, including 33,333 shares to Mr. Gerwitz.

During 2010, the Company sold 2,668,333 shares of its common stock to six non-affiliated individual investors, 148,912 shares of its common stock to Philip B. White, a Director, and 62,500 shares of its common stock to Herman M. Gerwitz, a Director, for a total of $101,600 pursuant to a private placement.